Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jarmo Kulmala
Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
A Dosimetric Phantom Study of Dose Accuracy and Build-Up Effects Using IMRT and RapidArc in Stereotactic Irradiation of Lung Tumours
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Cancerous Inhibitor of Protein Phosphatase 2A Regulates Cisplatin Resistance in Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
PLoS ONE
Multidisciplinary
Protein Phosphatase 2A (PP2A): A Key Phosphatase in the Progression of Chronic Obstructive Pulmonary Disease (COPD) to Lung Cancer
Respiratory Research
Pulmonary
Respiratory Medicine
Erlotinib Derivative Inhibits Hepatocellular Carcinoma by Targeting CIP2A to Reactivate Protein Phosphatase 2A
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Protein Phosphatase 2A (PP2A) Regulates Interleukin-4-Mediated STAT6 Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Is an Independent Prognostic Marker in Wild-Type KRAS Metastatic Colorectal Cancer After Colorectal Liver Metastasectomy
BMC Cancer
Cancer Research
Oncology
Genetics
Shwachman–Bodian–Diamond Syndrome (SBDS) Protein Is a Direct Inhibitor of Protein Phosphatase 2A (PP2A) Activity and Overexpressed in Acute Myeloid Leukaemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
FAM122A, a New Endogenous Inhibitor of Protein Phosphatase 2A
Oncotarget
Oncology
Protein Phosphatase 2A Signaling in Human Prostate Cancer
